This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
RNS Hotlist with Zak Mir: POLX, OKYO, ORCP, UPL, ALK, ROCK, SHN, ZEN, ENSI, FIRE & ATN
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
RNS Hotlist with Zak Mir: PLOB, TYM, ATN, IUG, CLON, POW, HFI, MSMN, CEL, BHL, IES, BRES, CORO, BLOE, TLY & JAY via Vox Markets
2023 already looks like it will be the year for life sciences companies. Poolbeg Pharma (POLB), a biopharmaceutical company, announced the strategic expansion of POLB 001 into oncology.